RFA

11 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
CellFX Console	Pulse Biosciences Inc Common Stock (DE) (PLSE)
Epicel	Vericel Corp (VCEL)
iheezo	HARROW, INC. (IMMY)
nevirapine	Mylan II B.V. (MYL)
nPulse Console	Pulse Biosciences Inc Common Stock (DE) (PLSE)
renuvion	Apyx Medical Corporation (APYX)

Phase 2(1)

Drug	Company
frunexian	Cadrenal Therapeutics, Inc. (CVKD)

Preclinical(3)

Unknown(1)

Drug	Company
AR101	AYTU BIOPHARMA, INC (AYTU)

BioSniper tracks 11 drugs in development for RFA across 7 companies.

There are 1 clinical trial targeting RFA tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.